Value of single-photon emission-computed tomography in acute stroke therapeutic trials. | Zendy

Sandra Hanson | Zendy; James C. Grotta | Zendy; Howard M. Rhoades | Zendy; Huyen Tran | Zendy; L. Lamki | Zendy; Bruce J. Barron | Zendy; William J. Taylor | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Value of single-photon emission-computed tomography in acute stroke therapeutic trials.

Author(s) -

Sandra Hanson,

James C. Grotta,

Howard M. Rhoades,

Huyen Tran,

L. Lamki,

Bruce J. Barron,

William J. Taylor

Publication year - 1993

Publication title -

stroke

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.397

H-Index - 319

eISSN - 1524-4628

pISSN - 0039-2499

DOI - 10.1161/01.str.24.9.1322

Subject(s) - medicine , cerebral blood flow , stroke (engine) , single photon emission computed tomography , barthel index , clinical trial , cerebral edema , emission computed tomography , cardiology , radiology , physical therapy , positron emission tomography , activities of daily living , mechanical engineering , engineering

New therapeutic interventions for acute ischemic stroke are aimed at improving cerebral blood flow in the first 3 to 6 hours after symptom onset. Single-photon emission-computed tomography (SPECT) performed in the setting of clinical therapeutic trials may give us a better understanding of the physiological response to new forms of treatment and could impact acute management decisions.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research